Jaime is a freelance writer for The American Journal of Managed Care® (AJMC®), where she previously worked as an assistant editor.
She has a BA in print journalism from Penn State University. You can connect with Jaime on LinkedIn.
Researchers Say Provider Education on Steroid Stewardship Is Warranted for AECOPD
The researchers found that just 13% of participating providers adhered to the recommended low dose (40 mg) of oral prednisone for patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
Survey Results Point to Differences Between Adult, Pediatric MPNs
Historically, there has been a lack of understanding around clinical and laboratory features and prognostic factors for children with myeloproliferative neoplasms (MPNs), as MPNs are especially rare in this patient population.
New Research Offers Key Safety, Early Efficacy Data on Zolgensma in SMA
A year after the FDA approved Zolgensma for the treatment of spinal muscular atrophy in children aged under 2 years without end-stage weakness, researchers shared safety and early efficacy data from the first 21 children treated with the gene therapy in Ohio.
Dying Patients With COPD Subjected to Testing Despite Shift to Comfort Care, Study Finds
Researchers found that 12% of patients underwent testing even after care teams determined they were actively dying of chronic obstructive pulmonary disease (COPD) and the aim of care shifted to comfort.
Researchers Highlight Need for Disease Registries Independent of Pharmaceutical Industry
As rare disease registries to assess orphan drugs are mainly established by the pharmaceutical industry, researchers argued post-marketing registries, functioning as marketing tools, have an underestimated influence on clinical practice.
Combined Training Program Improves Balance, Static Strength in Patients With MS
Results of a combined training program in 17 patients with multiple sclerosis indicate patients reap benefits from daily activities like walking or sitting-to-standing, and show the program reduces the dual-task cost of performing cognitive tasks while walking.
Review Finds Sarcopenia in COPD Drives Poorer Clinical Outcomes
A review on the diagnosis, prevalence, and clinical impact of sarcopenia in chronic obstructive pulmonary disease (COPD) has found that sarcopenia is both prevalent and negatively impacts clinical outcomes in patients with the disease.